Categories: LATEST NEWS

Qualcomm and Xiaomi announce new licensing agreement

The best kind of deal is one where both parties win. On Wednesday, December 2, Qualcomm Incorporated inked a new patent licensing agreement with Xiaomi that will allow the company, China’s second-largest smartphone maker, to develop, manufacture, and sell next-generation 3G and 4G devices.

China is one of the world’s hottest smartphone markets, and competition is fierce. Qualcomm, a leader in next-generation wireless technologies, has played a vital role in helping partners such as Xiaomi bring the future forward faster, to every corner of the globe. And once the ball gets rolling, it’s hard to stop.

“I do think that with every new licensing agreement we conclude, especially with more prominent licensees—and Xiaomi is one of them—we gain momentum,” says Eric Reifschneider, Senior Vice President and general manager of Qualcomm Technology Licensing (QTL). “It’s another sign that we are moving forward successfully with our licensing business in China.”

Liat

Recent Posts

Tower Semiconductor Secures $1.3 Billion Silicon Photonics Agreements and Reports Strong Q1 2026 Growth

Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…

3 days ago

14 Israeli Cybersecurity Companies Named to the Rising in Cyber 2026 List of the World’s Most Promising Cyber Startups

The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…

3 days ago

Sequent Selected by 15 Canadian Municipalities to Deliver Verifiable, Trust-Based Digital Voting for Elections

More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…

3 days ago

Sheba and Ichilov Medical Centers Join AccuLine’s International Clinical Trial for AI-Driven Early Heart Attack Risk Assessment

The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…

3 days ago

Molex Completes Acquisition of Teramount Ltd.

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…

6 days ago

Immunai Expands Oncology Collaboration, Extending AI-Driven Biomarker and Clinical Insights Through 2027

This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…

6 days ago